Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29076 - 29100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	GAS2L3	283431	downregulated	Dasatinib results in decreased expression of GAS2L3 mRNA	12q23.1	A21899
Dasatinib	Approved Investigational	GEN1	348654	downregulated	Dasatinib results in decreased expression of GEN1 mRNA	2p24.2	A21899
Dasatinib	Approved Investigational	GINS1	9837	downregulated	Dasatinib results in decreased expression of GINS1 mRNA	20p11.21	A21899
Dasatinib	Approved Investigational	GINS2	51659	downregulated	Dasatinib results in decreased expression of GINS2 mRNA	16q24.1	A21899
Dasatinib	Approved Investigational	GINS4	84296	downregulated	Dasatinib results in decreased expression of GINS4 mRNA	8p11.21	A21899
Dasatinib	Approved Investigational	GLIPR2	152007	upregulated	Dasatinib results in increased expression of GLIPR2 mRNA	9p13.3	A21899
Dasatinib	Approved Investigational	GPC4	2239	upregulated	Dasatinib results in increased expression of GPC4 mRNA	Xq26.2	A21899
Dasatinib	Approved Investigational	GPNMB	10457	upregulated	Dasatinib results in increased expression of GPNMB mRNA	7p15.3	A21899
Dasatinib	Approved Investigational	GREM2	64388	upregulated	Dasatinib results in increased expression of GREM2 mRNA	1q43	A21899
Dasatinib	Approved Investigational	GSTM5	2949	upregulated	Dasatinib results in increased expression of GSTM5 mRNA	1p13.3	A21899
Dasatinib	Approved Investigational	H2AFZ	3015	downregulated	Dasatinib results in decreased expression of H2AFZ mRNA	4q23	A21899
Dasatinib	Approved Investigational	HAPLN3	145864	upregulated	Dasatinib results in increased expression of HAPLN3 mRNA	15q26.1	A21899
Dasatinib	Approved Investigational	HAS2	3037	downregulated	Dasatinib results in decreased expression of HAS2 mRNA	8q24.13	A21899
Dasatinib	Approved Investigational	HBEGF	1839	downregulated	Dasatinib results in decreased expression of HBEGF mRNA	5q31.3	A21899
Dasatinib	Approved Investigational	HEG1	57493	upregulated	Dasatinib results in increased expression of HEG1 mRNA	3q21.2	A21899
Dasatinib	Approved Investigational	HELLS	3070	downregulated	Dasatinib results in decreased expression of HELLS mRNA	10q23.33	A21899
Dasatinib	Approved Investigational	HEPH	9843	upregulated	Dasatinib results in increased expression of HEPH mRNA	Xq12	A21899
Dasatinib	Approved Investigational	HERC2P10	390561	downregulated	Dasatinib results in decreased expression of HERC2P10 mRNA	15q13.2	A21899
Dasatinib	Approved Investigational	HERC4	26091	downregulated	Dasatinib results in decreased expression of HERC4 mRNA	10q21.3	A21899
Dasatinib	Approved Investigational	HIST1H1A	3024	downregulated	Dasatinib results in decreased expression of HIST1H1A mRNA	6p22.2	A21899
Dasatinib	Approved Investigational	HIST1H1B	3009	downregulated	Dasatinib results in decreased expression of HIST1H1B mRNA	6p22.1	A21899
Dasatinib	Approved Investigational	HIST1H1E	3008	downregulated	Dasatinib results in decreased expression of HIST1H1E mRNA	6p22.2	A21899
Dasatinib	Approved Investigational	HIST1H2BB	3018	downregulated	Dasatinib results in decreased expression of HIST1H2BB mRNA	6p22.2	A21899
Dasatinib	Approved Investigational	HIST1H2BH	8345	downregulated	Dasatinib results in decreased expression of HIST1H2BH mRNA	6p22.2	A21899
Dasatinib	Approved Investigational	HIST1H2BM	8342	downregulated	Dasatinib results in decreased expression of HIST1H2BM mRNA	6p22.1	A21899

Displaying entries 29076 - 29100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability